Dr. Noon CVD
Retina-based AI solution that predicts the future risk of cardiovascular disease risk
AI-powered Solution forCardiovascular Disease Risk Assessment
Dr. Noon CVD is a retina-based AI solution that predicts the future risk of cardiovascular disease.It is the world’s first AI-powered solution utilizing retinal imaging to assess cardiovascular risk.
In Korea, it is commercialized with regulatory approval and reimbursement, making it widely accessible in clinical practice. Globally, it is commercialized in Dubai, UK, and Italy with regulatory approvals in 8 regions. Adopted in many hospitals and clinics, it provides accurate, non-invasive, and cost-effective methods.
How Dr. Noon CVD
Uses AI for Cardiovascular Health
Cardiovascular diseases develop silently over time and can lead to fatal conditions such as heartattacks and strokes. Early detection is crucial to prevent severe complications before they occur.Watch the video to learn how Dr. Noon CVD leverages AI and retinal imagingfor cardiovascular risk assessment.
Patient Journey
Follow the step-by-step journey of a patient visiting the hospital and see how they meet Dr. Noon CVD.
Step 1: Patient Identification
If a patient is suspected of being at risk for cardiovascular disease such as those with diabetes, hypertension, hyperlipidemia, or obesity the Dr. Noon CVD is recommended.
Step 2: Clinical Consultation
A medical professional conducts a consultation, reviewing the patient’s medical history and current health status.
Step 3: Eye Scan
Take one picture of each eye to capture the retina.
Step 4: Image Upload
The retinal images are uploaded to the healthcare institution’s server or cloud platform.
Step 5: AI Analysis
Artificial intelligence automaticallyanalyzes the images to assess the patient’s risk of cardiovascular disease.
Step 6: Result Review
The risk of cardiovascular disease is determined through an automatically generated report.
Key Benefits
High Accuracy
Predicts cardiovascular disease risk with accuracy comparable to heart CT.
Safe & Non-Invasive
Requires no needle injection or radiation exposure, making it comfortable for patients.
Cost-Effective
Compared to conventional cardiovascular screenings, the test is available at a more affordable cost.
Fast Test Results
Results are delivered promptly, allowing patients to receive their reports without delay.
High Accessibility
Designed for wide use across clinics, hospitals, and health screening centers, enabling broader access to risk assessment.
Ready to Next Step?
Graha Kapital 1Jl. Kemang Raya No.4,Jakarta Selatan - Indonesia
Get in Touch →
In Collaboration with
Copyright © 2025 Mediwhale Inc.
All rights reserved.
Dr. Noon CVD
Retina-based AI solution that predicts the future risk of cardiovascular disease risk
AI-powered Solution forCardiovascular Disease Risk Assessment
Dr. Noon CVD is a retina-based AI solution that predicts the future risk of cardiovascular disease.It is the world’s first AI-powered solution utilizing retinal imaging to assess cardiovascular risk.
In Korea, it is commercialized with regulatory approval and reimbursement, making it widely accessible in clinical practice. Globally, it is commercialized in Dubai, UK, and Italy with regulatory approvals in 8 regions. Adopted in many hospitals and clinics, it provides accurate, non-invasive, and cost-effective methods.
How Dr. Noon CVD Uses AIfor Cardiovascular Health
Cardiovascular diseases develop silently over time and can lead to fatal conditions such as heartattacks and strokes. Early detection is crucial to prevent severe complications before they occur.Watch the video to learn how Dr. Noon CVD leverages AI and retinal imagingfor cardiovascular risk assessment.
Patient Journey
Follow the step-by-step journey of a patient visiting the hospital and see how they meet Dr. Noon CVD.
Step 1: Patient Identification
If a patient is suspected of being at risk for cardiovascular disease such as those with diabetes, hypertension, hyperlipidemia, or obesity the Dr. Noon CVD is recommended.
Step 2: Clinical Consultation
A medical professional conducts a consultation, reviewing the patient’s medical history and current health status.
Step 3: Eye Scan
Take one picture of each eye to capture the retina.
Step 4: Image Upload
The retinal images are uploaded to the healthcare institution’s server or cloud platform.
Step 5: AI Analysis
Artificial intelligence automaticallyanalyzes the images to assess the patient’s risk of cardiovascular disease.
Step 6: Result Review
The risk of cardiovascular disease is determined through an automatically generated report.
Key Benefits
High Accuracy
Predicts cardiovascular disease risk with accuracy comparable to heart CT.
Safe & Non-Invasive
Requires no needle injection or radiation exposure, making it comfortable for patients.
Cost-Effective
Compared to conventional cardiovascular screenings, the test is available at a more affordable cost.
Fast Test Results
Results are delivered promptly, allowing patients to receive their reports without delay.
High Accessibility
Designed for wide use across clinics, hospitals, and health screening centers, enabling broader access to risk assessment.
Ready to Next Step?
Graha Kapital 1Jl. Kemang Raya No.4,Jakarta Selatan - Indonesia
Get in Touch →
In Collaboration with
Copyright © 2025 Mediwhale Inc. All rights reserved.